Skip to main content

Table 1 Basal characteristics of the total study population and divided into genders

From: Gender difference in adiponectin associated with cardiovascular mortality

Variables

Total population

Males

Females

p-value

N

476

242

234

 

Age, mean (SD)

77.0 (3.4)

77.0 (3.2)

77.0 (3.7)

 

BMI, (SD)

27.2 (4.3)

26.7 (3.3)

27.6 (5.1)

0.02

IHD, n (%)

105 (22.1)

63 (26.0)

42 (17.9)

0.03

Hypertension, n (%)

359 (75.4)

174 (71.9)

185 (79.1)

0.003

ACEI/ARB, n (%)

125 (26.3)

64 (26.4)

61 (26.1)

0.93

Hb < 120 g/L, n (%)

51 (10.7)

16 (6.6)

35 (15.0)

0.003

Beta blockers, n (%)

168 (35.3)

90 (37.2)

78 (33.3)

0.38

b-glucose, mmol/L, mean, (SD)

4.6 (1.3)

4.5 (1.2)

4.6 (1.4)

0.57

HDL, mmol/L mean, (SD)

1.5 (0.4)

1.3 (0.3)

1.6 (0.4)

<0.0001

eGFR < 60 mL/min, n (%)

233 (48.9)

116 (47.9)

117 (50.0)

0.65

CRP, mg/L, mean (SD)

11.0 (5.1)

11.0 (5.0)

11.0 (5.3)

0.68

EF < 40 %, n (%)

36 (7.6)

27 (11.2)

9 (3.8)

0.003

NT-proBNP ng/L, mean, (SD)

188 (319)

201 (395)

174 (200)

0.37

Adiponectin pg/mL, mean, (SD)

6263 (4690)

4829 (3391)

7884 (5387)

<0.0001

  1. Notes: ACEI/ARB: Angiotensin converting enzyme inhibitor/Angiotensin receptor blocker; BMI: Body mass index; CRP: C-reactive protein; EF: Ejection fraction; eGRF: Estimated glomerular filtration rate; HDL; High density lipoproteins; IHD: Ischemic heart disease; NT-proBNP: N-terminal fragment of proBNP